About ASH | Patients | Media | Make a Gift | Corporate Supporters
Home > Education > Training > Reading >
  E-Mail This Page | Print This Page
MembershipMeetingsPublicationsEducation & CareersPolicy & PracticeASH Store


Find a Hematologist
Hematology Library

Blood
Image Bank
Education Program Book
ASH-SAP
Abstract Search
 
ASH Hematology Reading List

Porphyrias

Pathophysiology

Hemochromatosis genes and other factors contributing to the pathogenesis porphyria cutanea tarda.

Bulaj ZJ, Phillips JD, Ajioka RS, et al.
Blood. 2000;95:1565-1571.
Description: This paper reports the incidence of hemochromatosis gene mutations and other risk factors in porphyria cutanea tarda to help understand the contribution of inherited and acquired factors to the pathogenesis of this disease.
PubMed citation number: 10688809


Diagnosis

ACP Best Practice No 165: front line tests for the investigation of suspected porphyria.

Deacon AC, Elder GH.
J Clin Pathol. 2001;54:500-507.
Description: This article describes methods for the determination of urinary porphobilinogen, urinary and fecal total porphyrins, and total porphhrins in erythrocytes and plasma that are suitable for use in nonspecialist laboratories.
PubMed citation number: 11429419


Treatment

Acute porphyria: treatment with heme.

Tenhunen R, Mustajoki P.
Semin Liver Dis. 1998;18:53-55.
Description: This paper discusses the role of hematin and heme arginate in the role of treatment for porphyria and discusses the risks and benefits of both agents.
PubMed citation number: 9516678

Early administration of heme arginate for acute porphyric attacks.

Mustajoki P, Nordmann Y.
Arch Intern Med. 1993;153:2004-2008.
Description: This paper reports the outcome of patients experiencing an acute porphyric attack treated with heme arginate.
PubMed citation number: 8357285

Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation.

Tezcan I, Xu W, Gurgey A, et al.
Blood. 1998;92:4053-4058.
Description: This paper reports on the feasibility of allogenic bone marrow transplantation as having long-term biochemical and clinical effectiveness in select cases of erythropoietic porphyrias.
PubMed citation number: 9834209


Review

Childhood porphyrias.

Ahmed I.
Mayo Clin Proc. 2002;77:825-836.
Description: This paper reviews the pathophysiology of porphyrias and discusses the presentation and treatment of the most common disorders in children.
PubMed citation number: 12173716

The acute porphyries.

Elder GH, Hift RJ, Meissner PN.
Lancet. 1997;349:1613-1617.
Description: This is a concise review adapted from a seminar outlining the pathologic and clinical features of three major acute porphyrias.
PubMed citation number: 9174571

Erythropoietic and hepatic porphyrias.

Gross U, Hoffmann GF, Doss MO.
J Inherit Metab Dis. 2000;23:641-661.
Description: This comprehensive review covers the molecular genetics, manifestations, diagnosis, and treatment of the erythropoietic and hepatic porphyrias.
PubMed citation number: 11117426

Diagnosis and management of porphyria.

Thadani H, Deacon A, Peters T.
BMJ. 2000;320:1647-1651.
Description: This review concisely covers the diagnosis and management of both systemic and cutaneous porphyrias.
PubMed citation number: 10856069


Return to Table of Contents


Contact Us   |  Terms of Service   |   Privacy Policy  |  Photo Credit   |   RSS

1900 M Street, NW, Suite 200    Washington, DC 20036    Phone: 202-776-0544    Fax: 202-776-0545    E-mail: ash@hematology.org

©2008 American Society of Hematology